Skip to main content
Premium Trial:

Request an Annual Quote

Defense Dept. Gives Invitrogen $1.2M to Expand Use of ProtoArray in Biothreat Project

NEW YORK (GenomeWeb News) — Invitrogen said today that its Invitrogen Federal Systems subsidiary has been awarded a $1.2 million extension to its contract with the US Department of Defense.
 
According to Invitrogen, the contract will support research using its ProtoArray protein microarray platform to detect and analyze biothreat agents such as hemorrhagic fever viruses, poxviruses, and anthrax.  
 
This research builds on a technical assistance agreement with DoD for $970,000 initiated in January. That effort focused on the detection and analysis of smallpox and plague, Invitrogen said.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.